These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 4722053)

  • 1. Differential labelling of intraneuronal noradrenaline stores with different concentrations of (-)-3H-noradrenaline.
    Hughes J
    Br J Pharmacol; 1973 Feb; 47(2):428-30. PubMed ID: 4722053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of blockade of noradrenaline re-uptake on evoked tritium overflow from mouse vasa deferentia and rat cortex slices.
    el-Mas M; Hughes IE
    Br J Pharmacol; 1990 Nov; 101(3):762-8. PubMed ID: 2076491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of mechanisms controlling the release and inactivation of the adrenergic transmitter in the rabbit portal vein and vas deferens.
    Hughes J
    Br J Pharmacol; 1972 Mar; 44(3):472-91. PubMed ID: 4339251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential distribution in, and release from, sympathetic nerve endings of endogenous noradrenaline and recently incorporated catecholamines.
    Moura D; Azevedo I; Guimarães S
    Naunyn Schmiedebergs Arch Pharmacol; 1990 Aug; 342(2):153-9. PubMed ID: 2234100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic inhibition of monoamine oxidase reduces noradrenaline release in rat vas deferens and anococcygeus muscle.
    Hovevey-Sion D; Finberg JP
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Jul; 336(1):70-6. PubMed ID: 3114651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variation in noradrenaline output with changes in stimulus frequency and train length: role of different noradrenaline pools.
    Hughes J; Roth RH
    Br J Pharmacol; 1974 Jul; 51(3):373-81. PubMed ID: 4451751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of noradrenaline release by lysergic acid diethylamide.
    Hughes J
    Br J Pharmacol; 1973 Dec; 49(4):706-8. PubMed ID: 4788042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence that angiotensin enhances transmitter release during sympathetic nerve stimulation.
    Hughes J; Roth RH
    Br J Pharmacol; 1971 Feb; 41(2):239-55. PubMed ID: 4324592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of delta1-tetrahydrocannabinol on the release of (3H-(-)-noradrenaline from the isolated vas deferens of the rat.
    Graham JD; Lewis MJ; Li DM
    Br J Pharmacol; 1974 Oct; 52(2):233-6. PubMed ID: 4451818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of the dihydropyridine Bay K 8644 on the release of [3H]-noradrenaline from the rat isolated vas deferens.
    Ceña V; García AG; Khoyi MA; Salaices M; Sanchez-García P
    Br J Pharmacol; 1985 Jul; 85(3):691-6. PubMed ID: 2411327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of morphine on the release of noradrenaline from the mouse vas deferens.
    Henderson G; Hughes J
    Br J Pharmacol; 1976 Aug; 57(4):551-7. PubMed ID: 963343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of cocaine and imipramine on tyramine-induced release of noradrenaline-3H from the rat vas deferens in vitro.
    Barnett A; Staub M; Symchowicz S
    Br J Pharmacol; 1969 May; 36(1):79-84. PubMed ID: 5768130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of phenoxybenzamine on the uptake and metabolism of noradrenaline in the rat heart and vas deferens.
    Iversen LL; Langer SZ
    Br J Pharmacol; 1969 Nov; 37(3):627-37. PubMed ID: 5348466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoradiographic study of the rat vas deferens incubated with 3H-noradrenaline.
    Azevedo I; Moura D; Trendelenburg U
    Naunyn Schmiedebergs Arch Pharmacol; 1990 Aug; 342(2):245-8. PubMed ID: 2234107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stimulation-evoked release of [3H]-noradrenaline by 1, 10 or 100 pulses and its modification through presynaptic alpha 2-adrenoceptors.
    Marshall I
    Br J Pharmacol; 1983 Jan; 78(1):221-31. PubMed ID: 6297648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postjunctional inhibition of contractor responses in the mouse vas deferens by rat and human calcitonin gene-related peptides (CGRP).
    Al-Kazwini SJ; Craig RK; Marshall I
    Br J Pharmacol; 1986 May; 88(1):173-80. PubMed ID: 3486688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A maximum contraction and substantial quantities of tritium can be obtained from tetraethylammonium-treated [3H]-noradrenaline preloaded, rat vas deferens in response to a single electrical shock.
    Wakade AR
    Br J Pharmacol; 1980 Mar; 68(3):425-36. PubMed ID: 7052336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of noradrenaline release by adenosine.
    Wakade AR; Wakade TD
    J Physiol; 1978 Sep; 282():35-49. PubMed ID: 722535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The contractile response to and the release of noradrenaline by transmural nerve stimulation in the guinea-pig vas deferens and a comparison with the response to noradrenaline.
    Gillespie JS; Macrae IM
    Br J Pharmacol; 1983 Nov; 80(3):477-84. PubMed ID: 6416341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Release, metabolism and intraneuronal disposition of exogenous, endogenous and newly synthesized norepinephrine in the rat vas deferens.
    Eisenhofer G; Ropchak TG; Kopin IJ; Goldstein DS
    J Pharmacol Exp Ther; 1988 Apr; 245(1):81-8. PubMed ID: 3361453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.